Skip to content

Study · Randomized controlled trial · n = 30 · 2014

3 results

Risk of recurrent menorrhagia after hydrothermoablation: role of GnRH analogues neoadjuvant treatment in long-term successful rate.

Litta P, Saccardi C, Tommasi L, Di Giuseppe J, Delli Carpini G, Ciavattini A

Clinical and experimental obstetrics & gynecology1 Jan 2014Cited by 1 (Europe PMC)

PMID25134291 (opens in a new tab)DOI10.12891/ceog19372014 (opens in a new tab)PepBankPUB-25134291
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In women with menorrhagia, presurgical triptorelin reduced HTA failure at 12 months versus control (0% versus 20%).

    In plain wordsIn women with menorrhagia, presurgical triptorelin reduced HTA failure at 12 months versus control.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseHTA failure at 12 months
    Study

    n = 30

    Comparator
    HTA without presurgical triptorelin
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Measurements

    HTA failure rate
    0%
    Group A, presurgical triptorelin
    HTA failure rate
    20%
    Group B, control

    Source sentences

    Summary
    After 12 months of follow-up, Group A showed a significantly lower (0% vs 20%; p = 0.03) failure rate after hydrothermoablation than the Group B and a generally higher successful rate at 24 and 48 months.
    1 context sentence
    Summary · context
    A prospective randomized control study comparing 15 women (Group A) with presurgical subcutaneous triptorelin depot injection before HTA with controls (Group B, n = 15).
  2. 02HumanRandomized controlled trialEfficacy outcome

    In women with menorrhagia, presurgical triptorelin had generally higher HTA success at 24 and 48 months than control.

    In plain wordsIn women with menorrhagia, presurgical triptorelin had generally higher HTA success at 24 and 48 months than control.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    IncreaseHTA success at 24 and 48 months
    Study

    n = 30

    Comparator
    HTA without presurgical triptorelin
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    After 12 months of follow-up, Group A showed a significantly lower (0% vs 20%; p = 0.03) failure rate after hydrothermoablation than the Group B and a generally higher successful rate at 24 and 48 months.
    1 context sentence
    Summary · context
    A prospective randomized control study comparing 15 women (Group A) with presurgical subcutaneous triptorelin depot injection before HTA with controls (Group B, n = 15).
  3. 03HumanRandomized controlled trialSafety outcome

    In a trial of presurgical triptorelin before hydrothermal endometrial ablation, no perioperative or late complications were recorded.

    In plain wordsIn a trial of presurgical triptorelin before endometrial ablation, no perioperative or late complications were recorded.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    Not applicablePerioperative and late complications
    Study

    n = 30

    Outcome group
    Adverse events · Reproductive and sexual health
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    No perioperative and late complications were recorded.
    1 context sentence
    Summary · context
    A prospective randomized control study comparing 15 women (Group A) with presurgical subcutaneous triptorelin depot injection before HTA with controls (Group B, n = 15).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.